No pain, still gain (of function): the relation between sensory profiles and the presence or absence of self-reported pain in a large multicenter cohort of patients with neuropathy.


Journal

Pain
ISSN: 1872-6623
Titre abrégé: Pain
Pays: United States
ID NLM: 7508686

Informations de publication

Date de publication:
01 03 2021
Historique:
received: 17 04 2020
accepted: 22 07 2020
pubmed: 2 9 2020
medline: 20 5 2021
entrez: 2 9 2020
Statut: ppublish

Résumé

The pathophysiology of pain in neuropathy is complex and may be linked to sensory phenotypes. Quantitative sensory testing, a standardized method to evaluate sensory profiles in response to defined stimuli, assesses functional integrity of small and large nerve fiber afferents and central somatosensory pathways. It has revealed detailed insights into mechanisms of neuropathy, yet it remains unclear if pain directly affects sensory profiles. The main objective of this study was to investigate sensory profiles in patients with various neuropathic conditions, including polyneuropathy, mononeuropathy, and lesions to the central nervous system, in relation to self-reported presence or absence of pain and pain sensitivity using the Pain Sensitivity Questionnaire. A total of 443 patients (332 painful and 111 painless) and 112 healthy participants were investigated. Overall, loss of sensation was equally prevalent in patients with and without spontaneous pain. Pain thresholds were equally lowered in both patient groups, demonstrating that hyperalgesia and allodynia are just as present in patients not reporting any pain. Remarkably, this was similar for dynamic mechanical allodynia. Hypoalgesia was more pronounced in painful polyneuropathy, whereas hyperalgesia was more frequent in painful mononeuropathy (compared with painless conditions). Self-reported pain sensitivity was significantly higher in painful than in painless neuropathic conditions. Our results reveal the presence of hyperalgesia and allodynia in patients with central and peripheral lesions of the somatosensory system not reporting spontaneous pain. This shows that symptoms and signs of hypersensitivity may not necessarily coincide and that painful and painless neuropathic conditions may mechanistically blend into one another.

Identifiants

pubmed: 32868752
pii: 00006396-202103000-00008
doi: 10.1097/j.pain.0000000000002058
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

718-727

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 International Association for the Study of Pain.

Références

Attal N, Bouhassira D, Gautron M, Vaillant JN, Mitry E, Lepere C, Rougier P, Guirimand F. Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study. PAIN 2009;144:245–52.
Attal N, Fermanian C, Fermanian J, Lanteri-Minet M, Alchaar H, Bouhassira D. Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion? PAIN 2008;138:343–53.
Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med 2003;163:2433–45.
Baron R, Maier C, Attal N, Binder A, Bouhassira D, Cruccu G, Finnerup NB, Haanpaa M, Hansson P, Hullemann P, Jensen TS, Freynhagen R, Kennedy JD, Magerl W, Mainka T, Reimer M, Rice AS, Segerdahl M, Serra J, Sindrup S, Sommer C, Tolle T, Vollert J, Treede RD. Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles. PAIN 2017;158:261–72.
Blesneac I, Themistocleous AC, Fratter C, Conrad LJ, Ramirez JD, Cox JJ, Tesfaye S, Shillo PR, Rice ASC, Tucker SJ, Bennett DLH. Rare NaV1.7 variants associated with painful diabetic peripheral neuropathy. PAIN 2018;159:469–80.
Carleton RN, Sharpe D, Asmundson GJ. Anxiety sensitivity and intolerance of uncertainty: requisites of the fundamental fears? Behav Res Ther 2007;45:2307–16.
Carroll LJ, Cassidy JD, Cote P. Depression as a risk factor for onset of an episode of troublesome neck and low back pain. PAIN 2004;107:134–9.
Dunn LK, Durieux ME, Fernandez LG, Tsang S, Smith-Straesser EE, Jhaveri HF, Spanos SP, Thames MR, Spencer CD, Lloyd A, Stuart R, Ye F, Bray JP, Nemergut EC, Naik BI. Influence of catastrophizing, anxiety, and depression on in-hospital opioid consumption, pain, and quality of recovery after adult spine surgery. J Neurosurg Spine 2018;28:119–26.
Edwards RR. Individual differences in endogenous pain modulation as a risk factor for chronic pain. Neurology 2005;65:437–43.
Forstenpointner J, Naleschinski D, Wasner G, Hullemann P, Binder A, Baron R. Sensitized vasoactive C-nociceptors: key fibers in peripheral neuropathic pain. Pain Rep 2019;4:e709.
Gierthmuhlen J, Enax-Krumova EK, Attal N, Bouhassira D, Cruccu G, Finnerup NB, Haanpaa M, Hansson P, Jensen TS, Freynhagen R, Kennedy JD, Mainka T, Rice AS, Segerdahl M, Sindrup SH, Serra J, Tolle T, Treede RD, Baron R, Maier C. Who is healthy? Aspects to consider when including healthy volunteers in QST—based studies-a consensus statement by the EUROPAIN and NEUROPAIN consortia. PAIN 2015;156:2203–11.
Gierthmuhlen J, Schneider U, Seemann M, Freitag-Wolf S, Maihofner C, Enax-Krumova EK, Azad SC, Uceyler N, Birklein F, Maier C, Tolle T, Treede RD, Baron R. Can self-reported pain characteristics and bedside test be used for the assessment of pain mechanisms? An analysis of results of neuropathic pain questionnaires and quantitative sensory testing. PAIN 2019;160:2093–104.
Haroun OMO, Vollert J, Lockwood DN, Bennett DLH, Pai VV, Shetty V, Wakade AV, Khodke AS, Schilder A, Pfau D, Enax-Krumova EK, Maier C, Treede RD, Rice ASC. Clinical characteristics of neuropathic pain in leprosy and associated somatosensory profiles: a deep phenotyping study in India. Pain Rep 2019;4:e743.
Harter M, Reuter K, Gross-Hardt K, Bengel J. Screening for anxiety, depressive and somatoform disorders in rehabilitation—validity of HADS and GHQ-12 in patients with musculoskeletal disease. Disabil Rehabil 2001;23:737–44.
Kalliomaki M, Kieseritzky JV, Schmidt R, Hagglof B, Karlsten R, Sjogren N, Albrecht P, Gee L, Rice F, Wiig M, Schmelz M, Gordh T. Structural and functional differences between neuropathy with and without pain? Exp Neurol 2011;231:199–206.
Krause T, Asseyer S, Geisler F, Fiebach JB, Oeltjenbruns J, Kopf A, Villringer K, Villringer A, Jungehulsing GJ. Chronic sensory stroke with and without central pain is associated with bilaterally distributed sensory abnormalities as detected by quantitative sensory testing. PAIN 2016;157:194–202.
Landerholm AH, Hansson PT. Mechanisms of dynamic mechanical allodynia and dysesthesia in patients with peripheral and central neuropathic pain. Eur J Pain 2011;15:498–503.
Magerl W, Krumova EK, Baron R, Tolle T, Treede RD, Maier C. Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. PAIN 2010;151:598–605.
Malcangio M, Ramer MS, Jones MG, McMahon SB. Abnormal substance P release from the spinal cord following injury to primary sensory neurons. Eur J Neurosci 2000;12:397–9.
Marshall PWM, Schabrun S, Knox MF. Physical activity and the mediating effect of fear, depression, anxiety, and catastrophizing on pain related disability in people with chronic low back pain. PLoS One 2017;12:e0180788.
Orstavik K, Namer B, Schmidt R, Schmelz M, Hilliges M, Weidner C, Carr RW, Handwerker H, Jorum E, Torebjork HE. Abnormal function of C-fibers in patients with diabetic neuropathy. J Neurosci 2006;26:11287–94.
Pascal MMV, Themistocleous AC, Baron R, Binder A, Bouhassira D, Crombez G, Finnerup NB, Gierthmuhlen J, Granovsky Y, Groop L, Hebert HL, Jensen TS, Johnsen K, McCarthy MI, Meng W, Palmer CNA, Rice ASC, Serra J, Sola R, Yarnitsky D, Smith BH, Attal N, Bennett DLH. DOLORisk: study protocol for a multi-centre observational study to understand the risk factors and determinants of neuropathic pain. Wellcome Open Res 2018;3:63.
Pfau DB, Geber C, Birklein F, Treede RD. Quantitative sensory testing of neuropathic pain patients: potential mechanistic and therapeutic implications. Curr pain headache Rep 2012;16:199–206.
Pfau DB, Krumova EK, Treede RD, Baron R, Toelle T, Birklein F, Eich W, Geber C, Gerhardt A, Weiss T, Magerl W, Maier C. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): reference data for the trunk and application in patients with chronic postherpetic neuralgia. PAIN 2014;155:1002–15.
Phillips TJ, Brown M, Ramirez JD, Perkins J, Woldeamanuel YW, Williams AC, Orengo C, Bennett DL, Bodi I, Cox S, Maier C, Krumova EK, Rice AS. Sensory, psychological, and metabolic dysfunction in HIV-associated peripheral neuropathy: a cross-sectional deep profiling study. PAIN 2014;155:1846–60.
Raputova J, Srotova I, Vlckova E, Sommer C, Uceyler N, Birklein F, Rittner HL, Rebhorn C, Adamova B, Kovalova I, Kralickova Nekvapilova E, Forer L, Belobradkova J, Olsovsky J, Weber P, Dusek L, Jarkovsky J, Bednarik J. Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study. PAIN 2017;158:2340–53.
Reiter S, Eli I, Mahameed M, Emodi-Perlman A, Friedman-Rubin P, Reiter MA, Winocur E. Pain catastrophizing and pain persistence in temporomandibular disorder patients. J Oral Facial Pain Headache 2018;32:309–20.
Rolke R, Baron R, Maier C, Tolle TR, Treede RD, Beyer A, Binder A, Birbaumer N, Birklein F, Botefur IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihofner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. PAIN 2006;123:231–43.
Ruscheweyh R, Marziniak M, Stumpenhorst F, Reinholz J, Knecht S. Pain sensitivity can be assessed by self-rating: development and validation of the Pain Sensitivity Questionnaire. PAIN 2009;146:65–74.
Ruscheweyh R, Verneuer B, Dany K, Marziniak M, Wolowski A, Colak-Ekici R, Schulte TL, Bullmann V, Grewe S, Gralow I, Evers S, Knecht S. Validation of the pain sensitivity questionnaire in chronic pain patients. PAIN 2012;153:1210–18.
Rusu AC, Santos R, Pincus T. Pain-related distress and clinical depression in chronic pain: a comparison between two measures. Scand J pain 2016;12:62–7.
Samuelsson M, Leffler AS, Hansson P. Dynamic mechanical allodynia: on the relationship between temporo-spatial stimulus parameters and evoked pain in patients with peripheral neuropathy. PAIN 2005;115:264–72.
Samuelsson M, Leffler AS, Johansson B, Hansson P. On the repeatability of brush-evoked allodynia using a novel semi-quantitative method in patients with peripheral neuropathic pain. PAIN 2007;130:40–6.
Segerdahl AR, Themistocleous AC, Fido D, Bennett DL, Tracey I. A brain-based pain facilitation mechanism contributes to painful diabetic polyneuropathy. Brain 2018;141:357–64.
Sullivan M, Bishop S, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess 1995;7:524–32.
Themistocleous AC, Ramirez JD, Shillo PR, Lees JG, Selvarajah D, Orengo C, Tesfaye S, Rice AS, Bennett DL. The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy. PAIN 2016;157:1132–45.
Tracey I, Woolf CJ, Andrews NA. Composite pain biomarker signatures for objective assessment and effective treatment. Neuron 2019;101:783–800.
Turk DC, Dworkin RH, Trudeau JJ, Benson C, Biondi DM, Katz NP, Kim M. Validation of the hospital anxiety and depression scale in patients with acute low back pain. J Pain 2015;16:1012–21.
Uceyler N, Rogausch JP, Toyka KV, Sommer C. Differential expression of cytokines in painful and painless neuropathies. Neurology 2007;69:42–9.
Uceyler N, Vollert J, Broll B, Riediger N, Langjahr M, Saffer N, Schubert AL, Siedler G, Sommer C. Sensory profiles and skin innervation of patients with painful and painless neuropathies. PAIN 2018;159:1867–76.
Ueda H. Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. Pharmacol Ther 2006;109:57–77.
Vollert J, Attal N, Baron R, Freynhagen R, Haanpaa M, Hansson P, Jensen TS, Rice AS, Segerdahl M, Serra J, Sindrup SH, Tolle TR, Treede RD, Maier C. Quantitative sensory testing using DFNS protocol in Europe: an evaluation of heterogeneity across multiple centers in patients with peripheral neuropathic pain and healthy subjects. PAIN 2016;157:750–8.
Vollert J, Kramer M, Barroso A, Freynhagen R, Haanpaa M, Hansson P, Jensen TS, Kuehler BM, Maier C, Mainka T, Reimer M, Segerdahl M, Serra J, Sola R, Tolle TR, Treede RD, Baron R. Symptom profiles in the painDETECT Questionnaire in patients with peripheral neuropathic pain stratified according to sensory loss in quantitative sensory testing. PAIN 2016;157:1810–18.
Vollert J, Magerl W, Baron R, Binder A, Enax-Krumova EK, Geisslinger G, Gierthmuhlen J, Henrich F, Hullemann P, Klein T, Lotsch J, Maier C, Oertel B, Schuh-Hofer S, Tolle TR, Treede RD. Pathophysiological mechanisms of neuropathic pain: comparison of sensory phenotypes in patients and human surrogate pain models. PAIN 2018;159:1090–102.
Vollert J, Maier C, Attal N, Bennett DLH, Bouhassira D, Enax-Krumova EK, Finnerup NB, Freynhagen R, Gierthmuhlen J, Haanpaa M, Hansson P, Hullemann P, Jensen TS, Magerl W, Ramirez JD, Rice ASC, Schuh-Hofer S, Segerdahl M, Serra J, Shillo PR, Sindrup S, Tesfaye S, Themistocleous AC, Tolle TR, Treede RD, Baron R. Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations. PAIN 2017;158:1446–55.
Vollert J, Mainka T, Baron R, Enax-Krumova EK, Hullemann P, Maier C, Pfau DB, Tolle T, Treede RD. Quality assurance for Quantitative Sensory Testing laboratories: development and validation of an automated evaluation tool for the analysis of declared healthy samples. PAIN 2015;156:2423–30.
von Knorring L, Perris C, Eisemann M, Eriksson U, Perris H. Pain as a symptom in depressive disorders. II. Relationship to personality traits as assessed by means of KSP. PAIN 1983;17:377–84.
Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983;306:686–8.
Zhou XF, Chie ET, Deng YS, Zhong JH, Xue Q, Rush RA, Xian CJ. Injured primary sensory neurons switch phenotype for brain-derived neurotrophic factor in the rat. Neuroscience 1999;92:841–53.

Auteurs

Julia Forstenpointner (J)

Division of Neurological Pain Research and Therapy, Department of Neurology, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany.

Ruth Ruscheweyh (R)

Department of Neurology, Ludwig-Maximilians-University Hospital, Munich, Germany.

Nadine Attal (N)

INSERM U-987, Centre d'Evaluation et de Traitement de la Douleur, CHU Ambroise Paré, Boulogne-Billancourt, France, Université Versailles-Saint-Quentin, Versailles, France.

Ralf Baron (R)

Division of Neurological Pain Research and Therapy, Department of Neurology, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany.

Didier Bouhassira (D)

Department of Neurology, Ludwig-Maximilians-University Hospital, Munich, Germany.

Elena K Enax-Krumova (EK)

Department of Neurology, BG University Hospital Bergmannsheil GmbH, Ruhr-University Bochum, Bochum, Germany.

Nanna B Finnerup (NB)

Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Rainer Freynhagen (R)

Department of Anaesthesiology, Critical Care Medicine, Pain Therapy & Palliative Care, Pain Center Lake Starnberg, Benedictus Hospital Tutzing, Tutzing, Germany.
Anaesthesiological Clinic, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

Janne Gierthmühlen (J)

Division of Neurological Pain Research and Therapy, Department of Neurology, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Germany.

Per Hansson (P)

Department of Pain Management and Research, Division of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.
Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.

Troels S Jensen (TS)

Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.

Christoph Maier (C)

University Hospital of Pediatrics and Adolescent Medicine, Ruhr-University Bochum, Bochum, Germany.

Andrew S C Rice (ASC)

Pain Research, Department of Surgery and Cancer, Imperial College, London, United Kingdom.

Märta Segerdahl (M)

Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
MS Medical Consulting, Stockholm, Sweden.

Thomas Tölle (T)

Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

Rolf-Detlef Treede (RD)

Neurophysiology, Mannheim Center for Translational Neuroscience MCTN, Medical Faculty Mannheim, Ruprecht Karls University, Heidelberg, Germany.

Jan Vollert (J)

Pain Research, Department of Surgery and Cancer, Imperial College, London, United Kingdom.
Neurophysiology, Mannheim Center for Translational Neuroscience MCTN, Medical Faculty Mannheim, Ruprecht Karls University, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH